LON:IDH

Immunodiagnostic Systems (IDH) Share Price, News & Analysis

GBX 378
0.00 (0.00%)
(As of 07/12/2021)
Today's Range
378
378
50-Day Range
378
378
52-Week Range
180
380
Volume
N/A
Average Volume
14,539 shs
Market Capitalization
£108.80 million
P/E Ratio
290.77
Dividend Yield
0.01%
Price Target
N/A
IDH stock logo

About Immunodiagnostic Systems Stock (LON:IDH)

Immunodiagnostic Systems Holdings PLC develops, manufactures, and sells in-vitro diagnostic tests to the clinical laboratory market in the United Kingdom, the United States, Germany, France, and internationally. It develops, manufactures, and markets immunoassays and automated immunoanalyser technologies to provide diagnostic outcomes for patients. It offers IDS-iSYS multi-discipline automated systems, which is based on chemiluminescence and absorbency technology is used for immunoassay testing. The company provides its products and services for diagnosis of bone metabolism, calcium metabolism, hypertension, chronic kidney disease mineral bone disorder, growth, fertility, autoimmunity, infectious disease, sarcoidosis, and allergy. Immunodiagnostic Systems Holdings PLC was founded in 1977 and is headquartered in Boldon, the United Kingdom.

IDH Stock Price History

IDH Stock News Headlines

EQS-News: DATAGROUP Acquires ISC Innovative Systems Consulting AG
Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
IDH.L Regulatory News
Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
10 Best Leave Management Systems In 2023
Epic Systems
See More Headlines
Receive IDH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Immunodiagnostic Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
6/20/2018
Today
4/24/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Appliances & Equipment
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£34.25 million
Cash Flow
GBX 84 per share
Book Value
GBX 187.60 per share

Miscellaneous

Free Float
N/A
Market Cap
£108.80 million
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Jaap Stuut (Age 51)
    CEO & Director
    Comp: $284k
  • Mr. Paul J. Martin
    Group Fin. Director, Company Sec. & Director
  • Mr. Sander Perret Gentil
    Head of Marketing & Communications
  • Nicola Mitton
    Group HR Director
  • Mr. Ed Coombes (Age 50)
    Head Of Bus. Devel. - Instrumentation
  • Dr. Rudolf Schemer Ph.D. (Age 60)
    CEO of GeschTMaftsfuhrer at IDS GmbH Frankfurt & Country Mang. of Germany Region

IDH Stock Analysis - Frequently Asked Questions

How have IDH shares performed in 2024?

Immunodiagnostic Systems' stock was trading at GBX 378 at the beginning of 2024. Since then, IDH shares have increased by 0.0% and is now trading at GBX 378.
View the best growth stocks for 2024 here
.

How were Immunodiagnostic Systems' earnings last quarter?

Immunodiagnostic Systems Holdings PLC (LON:IDH) posted its earnings results on Wednesday, June, 20th. The company reported $5.70 earnings per share for the quarter, beating analysts' consensus estimates of $2.60 by $3.10.

Is Immunodiagnostic Systems a good dividend stock?

Immunodiagnostic Systems (LON:IDH) pays an annual dividend of GBX 0.02 per share and currently has a dividend yield of 0.50%. The dividend payout ratio is 1.46%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for IDH.

What other stocks do shareholders of Immunodiagnostic Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Immunodiagnostic Systems investors own include Dechra Pharmaceuticals (DPH), iShares Biotechnology ETF (IBB), Redrow (RDW), Netflix (NFLX), Sysco (SYY), TP ICAP Group (TCAP), Telford Homes (TEF), WisdomTree U.S. Multifactor Fund (USMF), American Tower (AMT) and Advanced Medical Solutions Group (AMS).

How do I buy shares of Immunodiagnostic Systems?

Shares of IDH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:IDH) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners